Selected article for: "acute sars cov respiratory syndrome coronavirus and admission prognosis"
Author: Russo, Vincenzo; Bottino, Roberta; Carbone, Andreina; Rago, Anna; Papa, Andrea Antonio; Golino, Paolo; Nigro, Gerardo
Title: COVID-19 and Heart: From Clinical Features to Pharmacological Implications
  • Cord-id: d5vmviai
  • Document date: 2020_6_22
    • ID: d5vmviai
    Snippet: A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clini
    Document: A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clinical features at hospital admission and prognosis for disease severity. The aim of our review is to describe the cardiological features of COVID-19 patients at admission, the acute cardiac presentation, the clinical outcome for patients with underlying CVD and the pharmacological implications for disease management.

    Search related documents:
    Co phrase search for related documents
    • ace ace inhibitor and aceis arbs: 1
    • ace inhibitor and aceis arbs: 1, 2, 3
    • ace inhibitor and activity increase: 1, 2, 3, 4
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute myocardial infarction: 1, 2
    • ace inhibitor and acute myocardial injury: 1
    • aceis arbs and activity increase: 1, 2
    • aceis arbs and acute ards respiratory distress syndrome: 1, 2, 3
    • aceis arbs and acute myocardial infarction: 1
    • activity increase and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • activity increase and acute myocardial infarction: 1, 2